AIDOT Inc.

AIDOT is proud to announced that our AI-based urinary stone detection and diagnostic support software, ‘URO dot AI’, has been designated as an innovative medical device by the Ministry of Food and Drug Safety (MFDS) under Integrated General Medical Device No. 81! This means that ‘URO dot AI’ can now be used as a non-reimbursed item in Korean medical settings, opening up opportunities to drive domestic revenue growth! This marks a significant step in combining cutting-edge technology with the healthcare industry for both better service and financial success. The software analyzes CT images to accurately detect urinary stones and precisely indicate their size and location, assisting medical professionals in diagnosing patients faster and more accurately. With a sensitivity of 97.89%, it can even detect stones as small as 0.7mm, providing crucial support in both quick diagnosis and post-treatment care. As the only AI product eligible for non-reimbursed billing for urinary stones, ‘URO dot AI’ is expected to make a huge impact on the market, driving rapid growth for AIDOT and enhancing medical care. With about 300,000 people seeing doctors for kidney stones annually in Korea, this AI technology is set to play a key role in improving patient outcomes. #HealthTech #AI #Innovation #UROdotAI #MedicalTechnology #HealthcareRevolution #AIInHealthcare #MedicalAI #AIDOT

URO dot AI, AI-powered urinary stone detection and diagnostic software, has officially received Class II medical device approval from the Ministry of Food and Drug Safety (MFDS) in South Korea! URO dot AI analyzes CT images to detect kidney, urinary tract, and bladder stones, displaying the size and location of detected stones to assist medical professionals in diagnosis. With a sensitivity of 97.89%, specificity of 94.12%, this software is a game changer in enhancing diagnostic accuracy. As a recognized innovative medical technology, our goal is to enhance diagnostic efficiency and minimize the time spent on manual image analysis. We are currently expanding our solution to include X-ray images and plan to accelerate global market entry through integration with extracorporeal shockwave lithotripsy equipment. At AIDOT, we’re committed to advancing medical technology to make healthcare smarter, faster, and more efficient for everyone. #HealthTech #AI #Innovation #UROdotAI #MedicalTechnology #HealthcareRevolution #AIInHealthcare #MedicalAI #AIDOT

🌸Free Cervical Cancer Screening Event in San Pedro Sula, Honduras!🌸 We’re excited to announce a FREE cervical cancer screening event in Honduras! From today until December 20th, join us for an important opportunity to screen for cervical cancer using Cerviray A.I. technology – at no cost! 🗓 When: December 13th – 20th 📍 Where: - Hospital Leonardo Martinez - Hospital Puerto Cortez - Hospital El Progreso - Hospital Santa Barbara - Policlínico Miguel Paz Barahona Cervical cancer is the second most prevalent cancer among women in Honduras, with over 850 diagnoses each year. Our AI system, Cerviray, will provide quick screenings, even in areas with limited medical resources. Let’s take steps together towards better health. Early detection saves lives!👩 #CervicalCancerScreening #AIHealthcare #Cerviray #Honduras #EarlyDetection #HealthMatters #Prevention #AIDOT

AIDOT’s URO dot AI Designated as Innovative Medical Device by MFDS! On December 3, our AI-based urinary stone detection and diagnostic software, URO dot AI, has been officially recognized as an innovative medical device by the Korean Ministry of Food and Drug Safety (MFDS). This marks the second innovation milestone for AIDOT, following the designation of our stomach cancer detection software, GIGA dot AI, earlier this year. Why URO dot AI is a game-changer? - Eliminates manual CT image analysis for urinary stone size (e.g., <4mm for insurance). - Enhances diagnostic accuracy, resource efficiency, and reduce medical experts' workload. Our development plans include expanding this solution to X-ray compatibility and integrating with HNT Medical’s extra-corporeal shock wave lithotripters for a comprehensive solution. AIDOT is committed to delivering cutting-edge technology to advance healthcare locally and globally.🌍 #AI #HealthcareInnovation #UROdotAI #MedicalTechnology #UrinaryStoneDetection #AIDOT

From November 29 to December 1, AIDOT successfully introduced our AI based cervical cancer screening system, Cerviray A.I., at the Asian Society of Gynecologic Oncology (ASGO) 2024 in Bali, Indonesia. As a Golden Sponsor, AIDOT hosted a Lunch Symposium where Prof. Dong-Hoon Suh from Seoul National University Bundang Hospital and Dr. Yudi Mulyana Hidayat, President of the Indonesian Society of Obstetricians and Gynecologists (POGI), presented on the innovations and clinical excellence of Cerviray AI. Cerviray AI empowers cervical cancer screening in remote areas with limited medical infrastructure, providing swift and easy diagnoses without the need for transport or lab facilities. With its ability to simplify cervical cancer detection, Cerviray AI has the potential to make a significant impact in preventing cervical cancer, especially in Indonesia’s remote islands. We are committed to continuous innovation and collaboration to establish AIDOT as a global leader in medical AI. #AI #Healthcare #CervicalCancer #CervirayAI #ASGO2024 #AIDOT

Participates in INASGO 2024 Conference November 29th,2024 – We, AIDOT Inc., are proud to announce its participation in the prestigious INASGO 2024 conference, currently being held in Bali of Indonesia. The event, which gathers leading experts and professionals from the fields of Gynecologic Oncology, provides a unique platform for the exchange of knowledge, research findings, and innovations. At INASGO 2024, AIDOT is showcasing its latest cervical cancer screening AI system named Cerviray A.I., reflecting its commitment to advancing the industry and contributing to groundbreaking discussions. The conference, which runs from Nov 29th to Dec 1st, features a series of keynote speeches, panel discussions, and networking opportunities. Please join our booth! #INASGO2024 #ASGO #Cervicalcancer #Cerviray #CervirayAI

AIDOT is participating in #MEDICA2024! AIDOT, as a leading innovator in AI-powered healthcare technologies, is participating in MEDICA 2024, the world’s largest and most influential medical trade fair, held in Düsseldorf, Germany. The event is held from November 13-16, brings together global healthcare professionals, industry leaders, and innovators from across the world. At this year’s MEDICA, AIDOT showcases its flagship AI diagnostic systems for cervical cancer and gastric cancer, Cerviray A.I. and GIGA dot AI. The company’s booth has attracted significant attention from healthcare professionals, medical institutions, and partners interested in the integration of artificial intelligence into diagnostics and patient care.  In addition to the AI diagnostic tools, AIDOT has highlighted its expertise in digital health solutions and ongoing projects that aim to bridge the digital divide in healthcare, particularly in underserved regions.  The participation in MEDICA 2024 reinforces AIDOT’s commitment to revolutionizing the healthcare industry through cutting-edge technology and partnerships with global stakeholders. As the company looks to expand its footprint in Europe and beyond, its presence at MEDICA is a significant step toward realizing its vision of a healthier, tech-enabled future for all. #AI #HealthcareInnovation #MEDICA #AIDOT

We’re pleased to share the launch of the “Cervical Cancer Free Umnugobi” initiated by our partner in Mongolia. This initiative aims to enhance women’s health in the Gobi region of Mongolia. Building on the “Test for Life” program, which has benefited over 40,000 women since 2005, a mobile clinic equipped with our AI-based cervical cancer screening technology will be deployed. This will help ensure early detection and better access to care in underserved rural communities. Our goal is to make a meaningful impact on cervical cancer prevention and screening in Mongolia, working toward a healthier future for women in the Gobi region. #TestForLifeGobi2024 #CervicalCancer #AI #AIDOT

Cervical cancer is the second most common cancer in the world. Early detection is key, and with our AI, it's more accessible than ever. In just a couple minutes, our artificial intelligent technology analyzes your results swiftly and accurately. No more waiting or uncomfortable procedures! 😌 Spread the word and join us in revolutionizing cervical cancer screening! 😄 #CervirayAI #Cerviray #Colposcope #Cervicography #Cervicalcancer #Screening https://lnkd.in/gutQHChx

We, AIDOT, are going to Bolivia for attending the event of prevention of cervical cancer!! See you all in Bolivia!! #Prevention #Cervicalcancer #Cerviray #CervirayAI #Artificialintelligence #with #KOICA #MSI #TRIAR #Bolivia